Forschung & Innovation
Publikationen
New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al
PMU Autor*innen
Tobias Kiesslich, Christian Mayr, Dino Bekric, Daniel Neureiter
Alle Autor*innen
Tobias Kiesslich, Christian Mayr, Dino Bekric, Daniel Neureiter
Fachzeitschrift
TRANSLATIONAL ONCOLOGY